Upjohn
Executive Summary
Generic versions of nonsteroidal anti-inflammatory drug Ansaid (flurbiprofen), oral anti-diabetic agent Micronase (glyburide) and acne treatment Cleocin-T Topical Solution (clindamycin) will be marketed "at a later date" by Ciba-Geigy generics subsidiary Geneva under an expanded agreement announced March 29. On Jan. 1, Upjohn formed Greenstone, Ltd. to supply Geneva with generic versions of the benzodiazepines Halcion (triazolam) and Xanax (alprazolam). Upjohn's patent for Ansaid expired Feb. 19. Micronase loses exclusivity May 1, 1994 and Cleocin-T is patented until July 13, 1993.